: Why the FDA didn’t grant an approval to Lilly’s Alzheimer’s drug

Romantic pensive woman with long wavy hairs hugging her husband with beard. Elegant couple sitting in cafe with hot cappuccino.

The regulator wants to see clinical data from at least 100 patients who have taken donanemab for a year